Forte Biosciences Inc (FBRX)

Currency in USD
76.8000
+0.1900(+0.25%)
Closed·
76.83000.0000(0.00%)
·
Advertisement
Earnings results expected in 11 days
FBRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
76.720076.8200
52 wk Range
9.910077.2000
Key Statistics
Prev. Close
76.61
Open
76.75
Day's Range
76.72-76.82
52 wk Range
9.91-77.2
Volume
1.68M
Average Volume (3m)
1M
1-Year Change
625.8979%
Book Value / Share
2.24
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FBRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
73.8000
Downside
-3.91%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Forte Biosciences Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

1 Buy
4 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 73.8000
(-3.91% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Barclays
Hold77.00+0.26%74.00Downgrade28/07/2026
Brookline Capital Markets
Hold77.00+0.26%-Downgrade27/07/2026
Evercore ISI
Hold77.00+0.26%-Downgrade27/07/2026
TD Cowen
Hold77.00+0.26%-Downgrade27/07/2026
Barclays
Buy74.00-3.65%-New Coverage21/07/2026

Earnings

Latest Release
11/05/2026
EPS / Forecast
-1.24 / -1.21
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Compare FBRX to Peers and Sector

Metrics to compare
FBRX
Peers
Sector
Relationship
P/E Ratio
−24.7x−5.3x−0.4x
PEG Ratio
−0.570.050.00
Price/Book
44.6x3.5x2.6x
Price / LTM Sales
-24.8x3.0x
Upside (Analyst Target)
0.5%93.5%51.8%
Fair Value Upside
Unlock−7.3%7.2%Unlock

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
6.59M26.96%504.98M
Other Institutional Investors
15.21M62.23%1.17B
Public Companies & Retail Investors
2.64M10.80%202.35M
Total
24.45M100.00%1.87B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Federated Hermes, Inc.8.63%2,110,516161,687
Fred Alger Management, LLC5.21%1,273,96597,598

People Also Watch

5.370
SBS
-1.11%
16.000
TH
+1.52%
14.68
CYRX
-3.74%
45.400
KOD
+4.10%
33.39
HIPO
+3.28%

FAQ

What Is the Forte Biosciences Inc (NASDAQ: FBRX) Share Price Today?

The Forte Biosciences Inc stock price today is 76.8000 USD.

What Stock Exchange Does Forte Biosciences Inc (FBRX) Trade On?

Forte Biosciences Inc is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Forte Biosciences Inc?

The stock symbol (also called a 'ticker') for Forte Biosciences Inc is "FBRX."

What Is the Current Forte Biosciences Inc Market Capitalisation?

As of today, Forte Biosciences Inc (NASDAQ: FBRX) market cap is 1.8800B USD.

What Is Forte Biosciences Inc's (FBRX) Earnings Per Share (TTM)?

The Forte Biosciences Inc EPS is currently -4.6459 (Trailing Twelve Months).

When Is the Next Forte Biosciences Inc Earnings Date?

Forte Biosciences Inc's next earnings report will be released on 17/08/2026.

Is FBRX a Buy or Sell From a Technical Analyst Perspective?

Based on today's Forte Biosciences Inc moving averages and other technical indicators, the daily buy/sell signal for FBRX stock is Strong Buy.

How Many Times Has Forte Biosciences Inc Stock Split?

Forte Biosciences Inc has split 2 times. (See the FBRX stock split history page for full effective split date and price information.)

How Many Employees Does Forte Biosciences Inc Have?

Forte Biosciences Inc has 22 employees, based on their latest Companies House report.

What is the current trading status of Forte Biosciences Inc (NASDAQ: FBRX)?

As of 06/08/2026, Forte Biosciences Inc (FBRX) is trading at a share price of 76.8000 USD, with a previous close of 76.6100 USD. The stock has fluctuated within a day range of 76.7200 USD to 76.8200 USD, while its 52-week range spans from 9.9100 USD to 77.2000 USD.

What Is Forte Biosciences Inc (FBRX) Price Target According to Analysts?

The average 12-month price target for Forte Biosciences Inc is 73.8000 USD, with a high estimate of 77 USD and a low estimate of 61 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an -3.91% Downside potential.

What Is the FBRX Premarket Price?

FBRX's last pre-market stock price is 76.7500 USD. The pre-market share volume is 422,020.0000, and the stock has decreased by 0.1400, or 0.1800%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.